124 related articles for article (PubMed ID: 37463100)
1. Homoharringtonine sensitizes pancreatic cancer to erlotinib by direct targeting and miRNA-130b-3p-mediated EphB4-JAK2-STAT3 axis.
Sarwar A; Zhu Z; Zhu M; Tang X; Su Q; Yang T; Tang W; Zhang Y
J Pharm Pharmacol; 2023 Oct; 75(10):1294-1309. PubMed ID: 37463100
[TBL] [Abstract][Full Text] [Related]
2. Targeting the Janus-activated kinase-2-STAT3 signalling pathway in pancreatic cancer using the HSP90 inhibitor ganetespib.
Nagaraju GP; Mezina A; Shaib WL; Landry J; El-Rayes BF
Eur J Cancer; 2016 Jan; 52():109-19. PubMed ID: 26682870
[TBL] [Abstract][Full Text] [Related]
3. miRNA-221-3p derived from M2-polarized tumor-associated macrophage exosomes aggravates the growth and metastasis of osteosarcoma through SOCS3/JAK2/STAT3 axis.
Liu W; Long Q; Zhang W; Zeng D; Hu B; Liu S; Chen L
Aging (Albany NY); 2021 Aug; 13(15):19760-19775. PubMed ID: 34388111
[TBL] [Abstract][Full Text] [Related]
4. BRM/SMARCA2 promotes the proliferation and chemoresistance of pancreatic cancer cells by targeting JAK2/STAT3 signaling.
Zhang Z; Wang F; Du C; Guo H; Ma L; Liu X; Kornmann M; Tian X; Yang Y
Cancer Lett; 2017 Aug; 402():213-224. PubMed ID: 28602977
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-216a inhibits pancreatic cancer by directly targeting Janus kinase 2.
Wang S; Chen X; Tang M
Oncol Rep; 2014 Dec; 32(6):2824-30. PubMed ID: 25220761
[TBL] [Abstract][Full Text] [Related]
6. STAT3/miR-130b-3p/MBNL1 feedback loop regulated by mTORC1 signaling promotes angiogenesis and tumor growth.
Li H; Liu P; Li D; Wang Z; Ding Z; Zhou M; Chen X; Miao M; Ding J; Lin W; Liu Y; Zha X
J Exp Clin Cancer Res; 2022 Oct; 41(1):297. PubMed ID: 36217202
[TBL] [Abstract][Full Text] [Related]
7. Homoharringtonine suppresses LoVo cell growth by inhibiting EphB4 and the PI3K/AKT and MAPK/EKR1/2 signaling pathways.
Shi X; Zhu M; Gong Z; Yang T; Yu R; Wang J; Zhang Y
Food Chem Toxicol; 2020 Feb; 136():110960. PubMed ID: 31726078
[TBL] [Abstract][Full Text] [Related]
8. MiR-130b is a prognostic marker and inhibits cell proliferation and invasion in pancreatic cancer through targeting STAT3.
Zhao G; Zhang JG; Shi Y; Qin Q; Liu Y; Wang B; Tian K; Deng SC; Li X; Zhu S; Gong Q; Niu Y; Wang CY
PLoS One; 2013; 8(9):e73803. PubMed ID: 24040078
[TBL] [Abstract][Full Text] [Related]
9. BRM transcriptionally regulates miR-302a-3p to target SOCS5/STAT3 signaling axis to potentiate pancreatic cancer metastasis.
Zhang Z; Li J; Guo H; Wang F; Ma L; Du C; Wang Y; Wang Q; Kornmann M; Tian X; Yang Y
Cancer Lett; 2019 May; 449():215-225. PubMed ID: 30790683
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA UCA1 regulates proliferation and apoptosis in multiple myeloma by targeting miR-331-3p/IL6R axis for the activation of JAK2/STAT3 pathway.
Li JL; Liu XL; Guo SF; Yang Y; Zhu YL; Li JZ
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9238-9250. PubMed ID: 31773675
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of miR-337-3p involved in the protection of CoCl
Li J; Wang T; Jiang XF
J Cell Biochem; 2019 Nov; 120(11):19076-19086. PubMed ID: 31264277
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-106a-3p Induces Apatinib Resistance and Activates Janus-Activated Kinase 2 (JAK2)/Signal Transducer and Activator of Transcription 3 (STAT3) by Targeting the SOCS System in Gastric Cancer.
Guo W; Li W; Yuan L; Mei X; Hu W
Med Sci Monit; 2019 Dec; 25():10122-10128. PubMed ID: 31884511
[TBL] [Abstract][Full Text] [Related]
13. Homoharringtonine suppresses tumor proliferation and migration by regulating EphB4-mediated β-catenin loss in hepatocellular carcinoma.
Zhu M; Gong Z; Wu Q; Su Q; Yang T; Yu R; Xu R; Zhang Y
Cell Death Dis; 2020 Aug; 11(8):632. PubMed ID: 32801343
[TBL] [Abstract][Full Text] [Related]
14. Cantharidin treatment inhibits hepatocellular carcinoma development by regulating the JAK2/STAT3 and PI3K/Akt pathways in an EphB4-dependent manner.
Zhu M; Shi X; Gong Z; Su Q; Yu R; Wang B; Yang T; Dai B; Zhan Y; Zhang D; Zhang Y
Pharmacol Res; 2020 Aug; 158():104868. PubMed ID: 32407961
[TBL] [Abstract][Full Text] [Related]
15. S-Adenosylmethionine synergistically enhances the antitumor effect of gemcitabine against pancreatic cancer through JAK2/STAT3 pathway.
Liu Y; Bi T; Liu L; Gao Q; Shen G; Qin L
Naunyn Schmiedebergs Arch Pharmacol; 2019 May; 392(5):615-622. PubMed ID: 30683944
[TBL] [Abstract][Full Text] [Related]
16. MiR-151a-3p Promotes Postmenopausal Osteoporosis by Targeting SOCS5 and Activating JAK2/STAT3 Signaling.
Fu Y; Xu Y; Chen S; Ouyang Y; Sun G
Rejuvenation Res; 2020 Aug; 23(4):313-323. PubMed ID: 31411118
[TBL] [Abstract][Full Text] [Related]
17. Homoharringtonine inhibited breast cancer cells growth via miR-18a-3p/AKT/mTOR signaling pathway.
Wang LB; Wang DN; Wu LG; Cao J; Tian JH; Liu R; Ma R; Yu JJ; Wang J; Huang Q; Xiong WY; Zhang X
Int J Biol Sci; 2021; 17(4):995-1009. PubMed ID: 33867824
[TBL] [Abstract][Full Text] [Related]
18. MiR-203 regulates JAK-STAT pathway in affecting pancreatic cancer cells proliferation and apoptosis by targeting SOCS3.
Lin XM; Chen H; Zhan XL
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6906-6913. PubMed ID: 31486490
[TBL] [Abstract][Full Text] [Related]
19. Melanoma cell-secreted exosomal miR-155-5p induce proangiogenic switch of cancer-associated fibroblasts via SOCS1/JAK2/STAT3 signaling pathway.
Zhou X; Yan T; Huang C; Xu Z; Wang L; Jiang E; Wang H; Chen Y; Liu K; Shao Z; Shang Z
J Exp Clin Cancer Res; 2018 Oct; 37(1):242. PubMed ID: 30285793
[TBL] [Abstract][Full Text] [Related]
20. Targeting EphA2 with miR-124 mediates Erlotinib resistance in K-RAS mutated pancreatic cancer.
Du J; He Y; Wu W; Li P; Chen Y; Hu Z; Han Y
J Pharm Pharmacol; 2019 Feb; 71(2):196-205. PubMed ID: 30604411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
